Canaan Equity Partners Ii Llc - Net Worth and Insider Trading
Canaan Equity Partners Ii Llc Net Worth
The estimated net worth of Canaan Equity Partners Ii Llc is at least $2.4 Billion dollars as of 2024-11-13. Canaan Equity Partners Ii Llc is the 10% Owner of DexCom Inc and owns about 32,650,160 shares of DexCom Inc (DXCM) stock worth over $2.4 Billion. Details can be seen in Canaan Equity Partners Ii Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Canaan Equity Partners Ii Llc has not made any transactions after 2005-11-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Canaan Equity Partners Ii Llc
Canaan Equity Partners Ii Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Canaan Equity Partners Ii Llc owns 2 companies in total, including EPIRUS Biopharmaceuticals Inc (EPRSQ) , and DexCom Inc (DXCM) .
Click here to see the complete history of Canaan Equity Partners Ii Llc’s form 4 insider trades.
Insider Ownership Summary of Canaan Equity Partners Ii Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EPRSQ | EPIRUS Biopharmaceuticals Inc | 2005-11-15 | 10 percent owner |
| DXCM | DexCom Inc | 2005-11-10 | 10 percent owner |
Canaan Equity Partners Ii Llc Latest Holdings Summary
Canaan Equity Partners Ii Llc currently owns a total of 1 stock. Canaan Equity Partners Ii Llc owns 32,650,160 shares of DexCom Inc (DXCM) as of November 10, 2005, with a value of $2.4 Billion.
Latest Holdings of Canaan Equity Partners Ii Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DXCM | DexCom Inc | 2005-11-10 | 32,650,160 | 74.34 | 2,427,212,894 |
Holding Weightings of Canaan Equity Partners Ii Llc
Canaan Equity Partners Ii Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Canaan Equity Partners Ii Llc has made a total of 0 transactions in DexCom Inc (DXCM) over the past 5 years. The most-recent trade in DexCom Inc is the sale of 16,848,000 shares on November 10, 2005, which brought Canaan Equity Partners Ii Llc around $14 Million.
Insider Trading History of Canaan Equity Partners Ii Llc
- 1
Canaan Equity Partners Ii Llc Trading Performance
Canaan Equity Partners Ii Llc Ownership Network
Ownership Network List of Canaan Equity Partners Ii Llc
Ownership Network Relation of Canaan Equity Partners Ii Llc
Canaan Equity Partners Ii Llc Owned Company Details
What does EPIRUS Biopharmaceuticals Inc do?
Who are the key executives at EPIRUS Biopharmaceuticals Inc?
Canaan Equity Partners Ii Llc is the 10 percent owner of EPIRUS Biopharmaceuticals Inc. Other key executives at EPIRUS Biopharmaceuticals Inc include Chief Financial Officer Thomas A. Shea , Chief Business Officer Vincent Aurentz , and director & Chief Executive Officer Amit Munshi .
EPIRUS Biopharmaceuticals Inc (EPRSQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
EPIRUS Biopharmaceuticals Inc (EPRSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
EPIRUS Biopharmaceuticals Inc Insider Transactions
Canaan Equity Partners Ii Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Canaan Equity Partners Ii Llc. You might contact Canaan Equity Partners Ii Llc via mailing address: 105 Rowayton Ave, Rowayton Ct 06853.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
